ADAM19 cleaves the PTH receptor and associates with brachydactyly type E.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 27 09 2023
revised: 25 01 2024
accepted: 25 01 2024
medline: 9 2 2024
pubmed: 9 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

Brachydactyly type E (BDE), shortened metacarpals, metatarsals, cone-shaped epiphyses, and short stature commonly occurs as a sole phenotype. Parathyroid hormone-like protein (PTHrP) has been shown to be responsible in all forms to date, either directly or indirectly. We used linkage and then whole genome sequencing in a small pedigree, to elucidate BDE and identified a truncated disintegrin-and-metalloproteinase-19 (ADAM19) allele in all affected family members, but not in nonaffected persons. Since we had shown earlier that the extracellular domain of the parathyroid hormone receptor (PTHR1) is subject to an unidentified metalloproteinase cleavage, we tested the hypothesis that ADAM19 is a sheddase for PTHR1. WT ADAM19 cleaved PTHR1, while mutated ADAM-19 did not. We mapped the cleavage site that we verified with mass spectrometry between amino acids 64-65. ADAM-19 cleavage increased G

Identifiants

pubmed: 38331475
pii: 7/4/e202302400
doi: 10.26508/lsa.202302400
pii:
doi:

Banques de données

PDB
['6fj3', '7vvl']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Aydin et al.

Auteurs

Atakan Aydin (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Christoph Klenk (C)

Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.

Katarina Nemec (K)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.
Department of Structural Biology and Center of Excellence for Data-Driven Discovery, St. Jude Children's Research Hospital, Memphis, TN, USA.

Ali Işbilir (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.

Lisa M Martin (LM)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Henrik Zauber (H)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Trendelina Rrustemi (T)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Hakan R Toka (HR)

https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Herbert Schuster (H)

https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Maolian Gong (M)

https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Sigmar Stricker (S)

Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.

Andreas Bock (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Rudolf-Boehm-Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Leipzig, Germany.

Sylvia Bähring (S)

https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Matthias Selbach (M)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Martin J Lohse (MJ)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
ISAR Bioscience Institute, Munich, Germany.

Friedrich C Luft (FC)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany friedrich.luft@charite.de.
https://ror.org/001w7jn25 Experimental and Clinical Research Center, A Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.

Classifications MeSH